AIDS News and Research

RSS

Common herpes drug Valacyclovir decreases HIV-1 levels

Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels — even when patients do not have herpes.

16 Mar 2015

Nomogram aids management of boys with constitutional delay in growth and puberty

A puberty nomogram is better than the classical criteria for identifying boys with constitutional delay in growth and puberty, report researchers.

13 Mar 2015

GHTC report confronts key challenge of renewing US leadership in global health technology

Today, the world is looking to the United States for cutting-edge diagnostics, drugs, and vaccines that could have the last word on an Ebola outbreak that is down but not out. But those innovations are the product of past US investments in research and development (R&D).

13 Mar 2015

Participation in anesthesiology simulation program boosts practice improvements

In 2010, the American Society of Anesthesiologists® (ASA®) introduced a mannequin-based simulation program to satisfy the American Board of Anesthesiology requirements for Maintenance of Certification in Anesthesiology (MOCA).

13 Mar 2015

TRMC expands use of capnography to monitor patients during moderate sedation

Tillamook Regional Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients during moderate sedation. Sedation is commonly used during procedures such as colonoscopies and in some instances can suppress breathing.

12 Mar 2015

Simple low-cost intervention could help reduce HIV-related deaths in Africa

A new approach to care for patients with advanced HIV in Tanzania and Zambia, combining community support and screening for a type of meningitis, has reduced deaths by 28%.

11 Mar 2015

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection.

9 Mar 2015

Scientists find gorilla origins in two human AIDS virus lineages

Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to an international team of scientists from the Perelman School of Medicine at the University of Pennsylvania, the University of Montpellier, the University of Edinburgh, and others.

3 Mar 2015

SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT).

2 Mar 2015

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).

28 Feb 2015

New research reveals that HIV latency is controlled by the virus itself

New research from the Gladstone Institutes for the first time provides strong evidence that HIV latency is controlled not by infected host cells, but by the virus itself. This fundamentally changes how scientists perceive latency, presenting it as an evolutionarily advantageous phenomenon rather than a biological accident.

27 Feb 2015

Three innovative research projects aim to improve lives of people with mobility difficulties

A prosthetic hand controlled by the nervous system, robotic clothing to help people with walking, and biosensors to monitor how patients use equipment or exercise during rehabilitation are the focus of three research projects awarded £5.3 million by the Engineering and Physical Sciences Research Council.

25 Feb 2015

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older.

24 Feb 2015

Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.

23 Feb 2015

Hiroshima University develops Sensorimotor Enhancing Suit to support human motion

A prototype for wearable equipment to support human motion has been developed at Hiroshima University, Japan. This wearable equipment, called the Sensorimotor Enhancing Suit (SEnS), enhances sensorimotor functions by reducing the muscle load of the upper limbs.

23 Feb 2015

Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Case Western Reserve University dental researcher Pushpa Pandiyan has discovered a new way to model how infection-fighting T cells cause inflammation in mice.

23 Feb 2015

Researchers review ten years of scientific studies on mitochondrial toxicity in pregnant women

Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.

20 Feb 2015

Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

A drug used to treat patients with Crohn's disease and multiple sclerosis has helped scientists confirm how "viral reservoirs" form in patients living with HIV and also proven effective in animal trials at blocking the pathways to those reservoirs in the brain and gut, a team of researchers reported recently in the journal PLOS Pathogens.

19 Feb 2015

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand--the first study to demonstrate that a vaccine can protect people from HIV infection.

19 Feb 2015

San Francisco AIDS Foundation unveils new mobile testing unit

On Valentine's Day, San Francisco AIDS Foundation unveiled a new mobile testing unit, an essential element in the plan to eliminate HIV transmission in San Francisco. The new unit—a 33-foot-long vehicle outfitted specifically for HIV and STI testing—will increase the availability of free testing in neighborhoods across the city at times when other HIV testing sites are closed.

19 Feb 2015

AIDS News and Research

Common herpes drug Valacyclovir decreases HIV-1 levels

Nomogram aids management of boys with constitutional delay in growth and puberty

GHTC report confronts key challenge of renewing US leadership in global health technology

Participation in anesthesiology simulation program boosts practice improvements

TRMC expands use of capnography to monitor patients during moderate sedation

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Scientists find gorilla origins in two human AIDS virus lineages

SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

New research reveals that HIV latency is controlled by the virus itself

Three innovative research projects aim to improve lives of people with mobility difficulties

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Hiroshima University develops Sensorimotor Enhancing Suit to support human motion

Case Western dental researcher discovers new way to model how T cells cause inflammation in mice

Researchers review ten years of scientific studies on mitochondrial toxicity in pregnant women

Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

San Francisco AIDS Foundation unveils new mobile testing unit

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News